Response to one COVID-19 vaccine dose strong in previously infected
Fatal police violence may be linked to preterm births in neighborhoods nearby
16 April 2021Chronic adverse effects from anti-PD-1 immunotherapies common
16 April 2021Response to one COVID-19 vaccine dose strong in previously infected
(HealthDay)—For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is higher after one dose of mRNA vaccine than after two vaccine doses among previously uninfected persons, according to a research letter published online April 14 in the New England Journal of Medicine.
